C-TERMINAL MODIFICATIONS OF NEUROPEPTIDE-Y AND ITS ANALOGS LEADING TO SELECTIVITY FOR THE MOUSE-BRAIN RECEPTOR OVER THE PORCINE SPLEEN RECEPTOR

被引:29
作者
KRSTENANSKY, JL
OWEN, TJ
PAYNE, MH
SHATZER, SA
BUCK, SH
机构
[1] Merrell Dow Research Institute, Cincinnati, OH 45215
关键词
D O I
10.1016/0143-4179(90)90073-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neuropeptide Y (NPY) is known to bind to at least two types of receptors (Y1 & Y2). One type (Y2) is able to bind and undergo activation by both NPY and its C-terminal fragments with good potency while the other (Y1) requires the full length of NPY for good potency. For most NPY analogs that have been examined, potency for the Y2 system (porcine spleen) is greater than or equal to that for the Y1 system (mouse brain), since the Y2 system is generally less selective. However, modifications of NPY and its analogs at position 34 can lead to materials with some Y1 selectivity. For example, [Pro34]-pNPY binds to mouse brain with an affinity of 0.14 nM. Its affinity for porcine spleen is 140 nM. [His34]-pNPY was also found to be Y1 selective (19-fold), but not to the degree of the [Pro340 analog (1000-fold). The Pro34 modification in the Y2 selective C-terminal fragment NPY(20-36) converted it into an essentially non-selective analog. The selectivity from the Pro34 substitution results from a loss of Y2 binding potency along with little effect on the Y1-receptor binding. Therefore, Y1 and Y2 receptors have differing requirements for the C-terminal region of NPY in addition to their different requirements for NPY's N-terminus. © 1990.
引用
收藏
页码:117 / 120
页数:4
相关论文
共 15 条
[1]   MOLECULAR-STRUCTURE OF MAMMALIAN NEUROPEPTIDE-Y - ANALYSIS BY MOLECULAR-CLONING AND COMPUTER-AIDED COMPARISON WITH CRYSTAL-STRUCTURE OF AVIAN HOMOLOG [J].
ALLEN, J ;
NOVOTNY, J ;
MARTIN, J ;
HEINRICH, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (08) :2532-2536
[2]  
BALASUBRAMANIAM A, 1987, INT J PEPT PROT RES, V29, P78
[3]  
BOUBLIK J, 1989, INT J PEPT PROT RES, V33, P11
[4]   SYNTHESIS AND HYPERTENSIVE ACTIVITY OF NEUROPEPTIDE-Y FRAGMENTS AND ANALOGS WITH MODIFIED N-TERMINI OR C-TERMINI OR D-SUBSTITUTIONS [J].
BOUBLIK, JH ;
SCOTT, NA ;
BROWN, MR ;
RIVIER, JE .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (03) :597-601
[5]   NOVEL PHARMACOLOGY OF SUBSTANCE-K-BINDING SITES - A 3RD TYPE OF TACHYKININ RECEPTOR [J].
BUCK, SH ;
BURCHER, E ;
SHULTS, CW ;
LOVENBERG, W ;
ODONOHUE, TL .
SCIENCE, 1984, 226 (4677) :987-989
[6]   [LEU31,PRO34]NEUROPEPTIDE-Y - A SPECIFIC Y-1 RECEPTOR AGONIST [J].
FUHLENDORFF, J ;
GETHER, U ;
AAKERLUND, L ;
LANGELANDJOHANSEN, N ;
THOGERSEN, H ;
MELBERG, SG ;
OLSEN, UB ;
THASTRUP, O ;
SCHWARTZ, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (01) :182-186
[7]  
GLOVER ID, 1985, EUR J BIOCHEM, V142, P379
[8]   THE SYNTHESIS, PHYSICAL CHARACTERIZATION AND RECEPTOR-BINDING AFFINITY OF NEUROPEPTIDE Y (NPY) [J].
KRSTENANSKY, JL ;
BUCK, SH .
NEUROPEPTIDES, 1987, 10 (01) :77-85
[9]   CENTRALLY TRUNCATED AND STABILIZED PORCINE NEUROPEPTIDE-Y ANALOGS - DESIGN, SYNTHESIS, AND MOUSE-BRAIN RECEPTOR-BINDING [J].
KRSTENANSKY, JL ;
OWEN, TJ ;
BUCK, SH ;
HAGAMAN, KA ;
MCLEAN, LR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (12) :4377-4381
[10]   NEUROPEPTIDE-Y RECEPTOR IN PIG SPLEEN - BINDING CHARACTERISTICS, REDUCTION OF CYCLIC-AMP FORMATION AND CALCIUM-ANTAGONIST INHIBITION OF VASOCONSTRICTION [J].
LUNDBERG, JM ;
HEMSEN, A ;
LARSSON, O ;
RUDEHILL, A ;
SARIA, A ;
FREDHOLM, BB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 145 (01) :21-29